Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Assets Average (2019 - 2025)

Bioadaptives' Assets Average history spans 7 years, with the latest figure at $198437.5 for Q3 2025.

  • For Q3 2025, Assets Average rose 619.92% year-over-year to $198437.5; the TTM value through Sep 2025 reached $198437.5, up 619.92%, while the annual FY2024 figure was $182941.5, 158.92% up from the prior year.
  • Assets Average for Q3 2025 was $198437.5 at Bioadaptives, up from $191481.5 in the prior quarter.
  • Across five years, Assets Average topped out at $216650.0 in Q4 2023 and bottomed at $25176.5 in Q1 2023.
  • The 5-year median for Assets Average is $117828.5 (2022), against an average of $112284.5.
  • The largest annual shift saw Assets Average tumbled 85.4% in 2024 before it skyrocketed 619.92% in 2025.
  • A 5-year view of Assets Average shows it stood at $163640.0 in 2021, then plummeted by 79.55% to $33464.5 in 2022, then skyrocketed by 547.4% to $216650.0 in 2023, then fell by 28.85% to $154139.0 in 2024, then grew by 28.74% to $198437.5 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Assets Average are $198437.5 (Q3 2025), $191481.5 (Q2 2025), and $186166.5 (Q1 2025).